LAMIVUDINE (has an active metabolite) | LAMIVUDINE | ATC J05AF05 ATC J05AR02 ATC J05AR11 ATC J05AR16 ATC J05AR12 ATC J05AR13 ATC J05AR24 ATC J05AR07 ATC J05AR01 ATC J05AR04 ATC J05AR05 ATC J05AR25 ATC J05AR27
ANTIINFECTIVES ANTIVIRAL ANTI-HIV AGENTS ANTI-HBV AGENTS NUCLEOSIDE AND NUCLEOTIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIS) | ORAL | Cmax 15.1 MICROMOLAR (300 MILLIGRAM) PMID11605717 Tmax 1.3 HOUR F 87 PERCENT VD 84.5 LITER (65 KILOGRAM) PPB 36 PERCENT Cl 23.9 LITER / HOUR HT 6 HOUR SOLUBILITY OF 70 MILLIGRAM / MILLILITER IN WATER | REVERSE TRANSCRIPTASE (GAG-POL POLYPROTEIN) PDB 2NOA (THE STRUCTURE OF DEOXYCYTIDINE KINASE COMPLEXED WITH LAMIVUDINE AND ADP.) LIGAND CODE = 3TC (link to the list of PDB complexes) Download experimental 3D coordinates of 3TC with added hydrogens | HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE INHIBITOR CHEMBL247 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE Q72547 REVERSE TRANSCRIPTASE/RNASEH HUMAN IMMUNODEFICIENCY VIRUS 1 ENZYME HYDROLASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |